Vaccine Experts Inject Realism Into US Gov't's COVID-19 Timeline

The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval. 

PS2004_Vaccine Vial_1046242816_1200.jpg
It is unlikely a COVID-19 vaccine will be widely available in 12 to 18 months, experts say • Source: Shutterstock

Skepticism abounds that a COVID-19 vaccine might be ready for wide-scale immunization in 12 to 18 months despite predictions from both scientific leaders and politicians in the Trump administration.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Vaccines

More from Pink Sheet